Rachel Langland, MD
Family Medicine · Glendale, AZNPI 1164411849
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $81,372 of the $82,964 with a category attached, or 98.1%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 98.1% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2022 at $23,463 and has fallen 58.7% since, to $9,686 in 2024. Among family medicine clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $674.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$81K
- Novo Nordisk$251
- AstraZeneca$177
- Lilly USA, LLC$146
- Amarin Pharma, Inc.$142
- Edwards Lifesciences$140
- plus $721 from 18 others
What the payments were for
- Consulting fees$81,37298%
- Food & beverage$1,5772%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 45 | $81,387 |
| Novo Nordisk | 12 | $251 |
| AstraZeneca | 13 | $177 |
| Lilly USA, LLC | 12 | $146 |
| Amarin Pharma, Inc. | 2 | $142 |
| Edwards Lifesciences | 1 | $140 |
| Amgen | 3 | $125 |
| Pfizer | 6 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $84 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $61 |
| Boston Scientific | 2 | $41 |
| Abbott | 2 | $38 |
| Arbor Pharmaceuticals, Inc. | 3 | $38 |
| Medtronic | 2 | $37 |
| AbbVie | 2 | $36 |
| Johnson & Johnson | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Merck | 2 | $22 |
| Silk Road Medical, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $16 |
| GSK | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Medicure Pharma Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SAPIEN 3 Ultra RESILIA$140
- Vascepa$122
How this compares
$82,964 in reported general payments places this provider in the 95th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $8,162 |
| Levothyroxine Sodium | 16 | $207 |
| Losartan Potassium | 11 | $167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $94 | $8,16215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Glendale
- Kecia SmetteGlendale$41K
- Donald MiddletonGlendale$24K
- Michaela SkellyGlendale$21K
- Clark WysongGlendale$14K
- Douglas CunninghamPhoenix$1.8M
- Mitchell EdelsteinPhoenix$741K
- Lorena Jauregui-CovarrubiasYuma$491K
- Sam FereidouniScottsdale$486K
- Jessica BlancoChandler$447K
- Heather ElwoodPhoenix$236K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.